Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002328 · ClinicalTrials.gov registry record · NA
Azithromycin in the Treatment of Cryptosporidiosis in Patients Who Have Not Had Success With Other Drugs
A NA study, sponsored by Pfizer.
- Completed
- Registry status
- NA
- Development phase
NCT00002328: Completed NA study, sponsored by Pfizer.
NCT00002328 is a NA study that has completed, run by Pfizer. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002328, a NA study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
To provide azithromycin for the treatment of individual patients with proven cryptosporidiosis whose disease has persisted or progressed despite prior therapies.
Interventions
- DRUG Azithromycin
Trial Details
| Field | Value |
|---|---|
| Phase | NA |
What the finished NCT00002328 record still lists
NCT00002328 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Azithromycin is the first listed.
NCT00002328 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00002328 about?
NCT00002328 is a clinical study titled "Azithromycin in the Treatment of Cryptosporidiosis in Patients Who Have Not Had Success With Other Drugs". To provide azithromycin for the treatment of individual patients with proven cryptosporidiosis whose disease has persisted or progressed despite prior therapies.
What is the current status of trial NCT00002328?
This trial is currently completed. It is a NA study.
What interventions are being tested in trial NCT00002328?
The interventions under investigation include: Azithromycin (DRUG).
Who is sponsoring clinical trial NCT00002328?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.